CEACAM5 and neoplasm: In fact, patient- and mouse-derived organoids have been used to study tumor immunology and immunotherapy adding checkpoint inhibitors to such types of short-term cultures 14-17 and also in the study of resistance mechanisms to anti- CEA T cell engagers 18.